Nonbiologic drugs in pediatric rheumatology

Anand Prahalad Rao, Nutan Kamath

Research output: Chapter in Book/Report/Conference proceedingChapter


The field of pediatric rheumatology has seen a decisive change in the way patients are being treated in last few decades. The diseases of this subspeciality be it JIA, SLE, vasculitis or JDM are chronic and require long term term treatment with drugs. The discovery of new drugs including BRMs and intelligent use of older drugs have made it possible to achieve remission in many of these conditions and provide patients with a better quality of life. This chapter highlights the pharmacology, intended uses and possible adverse side effects of many of these drugs. The information provided in this chapter should be a precursor for treating children with rheumatological illness.

Original languageEnglish
Title of host publicationPediatric Rheumatology
Subtitle of host publicationA Clinical Viewpoint
PublisherSpringer Science+Business Media Singapore Private Limited
Number of pages21
ISBN (Electronic)9789811017506
ISBN (Print)9789811017490
Publication statusPublished - 01-01-2016

All Science Journal Classification (ASJC) codes

  • General Medicine


Dive into the research topics of 'Nonbiologic drugs in pediatric rheumatology'. Together they form a unique fingerprint.

Cite this